![Acelity V.A.C.ULTA Safety Information And Application Instructions Download Page 12](http://html2.mh-extra.com/html/acelity/v-a-c-ulta/v-a-c-ulta_safety-information-and-application-instructions_3939654012.webp)
12
Pressure Points:
Periodically assess and monitor the location of tubing connectors, caps, clamps or
other rigid components to ensure they do not create inadvertent pressure points in relation to patient
position�
V.A.C.Ulta™ Therapy Unit Pressure Excursions:
In rare instances, tubing blockages with the
V�A�C�Ulta™ Therapy Unit may result in brief vacuum excursions to more than 250 mmHg negative
pressure� Resolve alarm conditions immediately� Refer to the V�A�C�Ulta™ Therapy System User Manual or
contact your KCI Representative for additional information�
ADDITIONAL PRECAUTIONS FOR V.A.C. VERAFLO™ THERAPY
Suitable Solutions:
V�A�C� VeraFlo™ Therapy is intended for use with V�A�C� VeraFlo™
Therapy disposables and topical wound treatment solutions and suspensions� Only use
solutions or suspensions that are:
•
Indicated for topical wound treatment according to solution manufacturer’s
instructions for use� Some topical agents may not be intended for extended tissue
contact� If in doubt about the appropriateness of using a particular solution for
V�A�C� VeraFlo™ Therapy, contact the solution’s manufacturer about its suitability for
saturated topical wound exposure�
•
Compatible with V�A�C�® Dressings and disposable components� Contact your KCI
Representative for a list of solutions shown to be compatible with V�A�C�® Dressings
and disposable components�
NOTE:
Hypochlorous acid solutions applied frequently at high concentrations
can lead to significant material degradation. Consider utilizing concentrations and
exposure durations as low as clinically relevant
�
NOTE:
The V.A.C. GranuFoam Silver® Dressing is not intended to be used with V.A.C.
VeraFlo™ Therapy because instillation solutions may negatively impact the benefits of
the V.A.C. GranuFoam Silver® Dressing.
Canister Changes:
Monitor fluid level in canisters frequently during use of the V�A�C�
VeraFlo™ Therapy� Frequent canister changes may be necessary depending on volume of
fluid instilled and wound exudates� At a minimum the canister should be changed weekly
and disposed of according to institutional protocol�
Summary of Contents for V.A.C.ULTA
Page 2: ...EN...
Page 29: ...29...
Page 32: ...DE...
Page 59: ...59...
Page 62: ...62 NL...
Page 89: ...89...
Page 92: ...FR...
Page 119: ...119...
Page 122: ...IT...
Page 149: ...149...
Page 152: ...ES...
Page 179: ...179...
Page 182: ...DA...
Page 209: ...209...
Page 212: ...SV...
Page 239: ...239...
Page 242: ...PT BR...
Page 269: ...269...
Page 272: ...TR...
Page 299: ...299...
Page 301: ...EL V A C ULTA V A C ULTA V A C VERAFLO V A C Ulta KCI Rx Only...
Page 302: ...EL...
Page 307: ...307 V A C V A C VeraFlo V A C VeraFlo V A C V A C VeraFlo 1000 mL 1000 mL...
Page 317: ...317 3M Cavilon 3M Cavilon 3M Cavilon V A C Advanced 3M Cavilon 5 6 7...
Page 326: ...326 V A C VERAFLO 1 2 25 mmHg 30 5 cm 2 5 cm 3 cm 28 29 30 31 32 33 34 35 36 37 38...
Page 328: ...328 V A C VERAFLO 1 V A C VeraFlo 2 V A C VeraT R A C 39 39...
Page 329: ...329...
Page 332: ...FI...
Page 359: ...359...
Page 362: ...362 NO...
Page 389: ...389...
Page 395: ...395...